![Matthew Ivory](https://profiles-cardiff.imgix.net/attachments/2925?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Trosolwyg
Cymwysterau
- PhD: Ysgol Fferylliaeth a Gwyddorau Fferyllol, Prifysgol Caerdydd (2016)
- GPhC: Cofrestru proffesiynol (2012)
- Gradd fferylliaeth (MPharm): Anrhydedd Dosbarth Cyntaf, Prifysgol Caerdydd (2011)
Cyhoeddiad
2024
- Hughes, L., Bowen, J., Davies, W., Deslandes, R., Ivory, M. and Kingman, S. 2024. When pharmacy and theater collide: How diversity can develop inclusive communication skills. Currents in Pharmacy Teaching and Learning 16(6), pp. 460-464. (10.1016/j.cptl.2024.03.005)
2019
- Maarifi, G. et al. 2019. Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells. Cellular and Molecular Immunology 17, pp. 547-549. (10.1038/s41423-019-0302-5)
2016
- Czubala, M. A. et al. 2016. TGFβ induces a SAMHD1-independent post-entry restriction to HIV-1 infection of human epithelial Langerhans cells. Journal of Investigative Dermatology 136(10), pp. 1981-1989. (10.1016/j.jid.2016.05.123)
- Caucheteux, S. M. et al. 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136(6), pp. 1172-1181. (10.1016/j.jid.2016.01.033)
- Ivory, M. O. 2016. Characterising skin immune cells to inform development of intradermal vaccines and therapeutics. PhD Thesis, Cardiff University.
2015
- Ivory, M. O., Birchall, J. C. and Piguet, V. 2015. Early dengue virus infection in human skin: a cycle of inflammation and infectivity [Commentary]. Journal of Investigative Dermatology 135(7), pp. 1711-1712. (10.1038/jid.2014.544)
2010
- Pearton, M. et al. 2010. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28(37), pp. 6104-6113. (10.1016/j.vaccine.2010.05.055)
- Pearton, M., Kang, S. M., Song, J. M., Anstey, A. V., Ivory, M. O., Compans, R. W. and Birchall, J. C. 2010. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS ONE 5(8), article number: e12410. (10.1371/journal.pone.0012410)
Articles
- Hughes, L., Bowen, J., Davies, W., Deslandes, R., Ivory, M. and Kingman, S. 2024. When pharmacy and theater collide: How diversity can develop inclusive communication skills. Currents in Pharmacy Teaching and Learning 16(6), pp. 460-464. (10.1016/j.cptl.2024.03.005)
- Maarifi, G. et al. 2019. Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells. Cellular and Molecular Immunology 17, pp. 547-549. (10.1038/s41423-019-0302-5)
- Czubala, M. A. et al. 2016. TGFβ induces a SAMHD1-independent post-entry restriction to HIV-1 infection of human epithelial Langerhans cells. Journal of Investigative Dermatology 136(10), pp. 1981-1989. (10.1016/j.jid.2016.05.123)
- Caucheteux, S. M. et al. 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136(6), pp. 1172-1181. (10.1016/j.jid.2016.01.033)
- Ivory, M. O., Birchall, J. C. and Piguet, V. 2015. Early dengue virus infection in human skin: a cycle of inflammation and infectivity [Commentary]. Journal of Investigative Dermatology 135(7), pp. 1711-1712. (10.1038/jid.2014.544)
- Pearton, M. et al. 2010. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28(37), pp. 6104-6113. (10.1016/j.vaccine.2010.05.055)
- Pearton, M., Kang, S. M., Song, J. M., Anstey, A. V., Ivory, M. O., Compans, R. W. and Birchall, J. C. 2010. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS ONE 5(8), article number: e12410. (10.1371/journal.pone.0012410)
Thesis
- Ivory, M. O. 2016. Characterising skin immune cells to inform development of intradermal vaccines and therapeutics. PhD Thesis, Cardiff University.
Ymchwil
Diddordebau ymchwil
Cyflwyno brechlynnau a therapiwteg i'r croen
Mae croen dynol yn cynrychioli targed delfrydol ar gyfer cyflwyno therapiwteg oherwydd ei hygyrchedd a'i osgoi metaboledd pasio cyntaf. Yn benodol, gall cyflwyno brechlynnau'n fewndermaidd fanteisio ar boblogaethau amrywiol celloedd imiwnedd sy'n bresennol i ganiatáu ar gyfer imiwneiddio gyda llai o ddosau antigen o'i gymharu â'r llwybr pigiad mewngyhyrol wedi'i ymarfer. Mae'r is-setiau lluosog o gelloedd dendritig dermol dynol a'u rolau wrth dderbyn, prosesu a chyflwyno antigen brechlyn i ennyn ymatebion imiwnedd ochr yn ochr â chelloedd epidermal Langerhans yn dal i gael eu trafod ac felly mae ymchwil yn y maes hwn yn hanfodol i lywio dyluniad brechlyn yn y dyfodol.
Addysgu
MPharm undergraduate teaching
- PH1122 - The Role of The Pharmacist in Professional Practice
- PH1123 - Structure and Function of Cells and Microbes
- PH2107 - Formulation Science I
- PH3110 - Optimisation of Pharmaceutical Care
- PH3202 - Research Methodology
- PH4116 - Pharmacy Research or Scholarship Project
- PH4118 - Pharmaceutical Sciences, Pharmacy Practice and the Patient
Bywgraffiad
Proffil gyrfa
- Gorffennaf 2016 - Darlithydd Presennol, Ysgol Fferylliaeth a Gwyddorau Fferyllol, Prifysgol Caerdydd.
- Medi 2015 - Hydref 2015 Ymweld Ymchwilydd, Adran Imiwnoleg a Bioleg Celloedd, Prifysgol Osaka, Japan.
- Hydref 2012 - Medi 2016 Myfyriwr Ymchwil Ôl-raddedig, Ysgol Fferylliaeth a Gwyddorau Fferyllol, Prifysgol Caerdydd.
- Awst 2012 - Presennol Fferyllydd Lotum, gwahanol leoliadau.
- Awst 2011 - Jul 2012 Fferyllydd Cyn-gofrestru, Bryste-Myers Squibb a St Helens and Knowsley Teaching Hospitals NHS Trust, Glannau Mersi.
- Medi 2007 - Gorffennaf 2011 Myfyriwr Israddedig (MPharm), Ysgol Fferylliaeth a Gwyddorau Fferyllol, Prifysgol Caerdydd.
Arbenigedd Allweddol
- Diwylliant a histoleg organau croen dynol cyn-vivo (imiwnocemeg ac imiwnofluorescence)
- Echdynnu a diwylliant celloedd imiwnedd croen dynol
- Cymesuredd llif
- Ffurfiad fferyllol
